Form 4: Royalty Pharma Director Bonnie L. Bassler Acquires Shares in Lieu of Retainer

Director Bonnie L. Bassler acquired 1,342 Class A Ordinary Shares of Royalty Pharma plc in lieu of a quarterly retainer payment.

Summary

• On September 30, 2024, Bonnie L. Bassler, a director of Royalty Pharma plc, acquired 1,342 Class A Ordinary Shares.
• The shares were issued under the Issuer's 2020 Independent Director Equity Incentive Plan.
• The acquisition was in lieu of a quarterly retainer payment of $37,500, with the shares acquired at a price of $27.9249 each.
• Following the transaction, Bassler directly owns 59,796 Class A Ordinary Shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company, aligning interests with shareholders. The transaction itself is routine and expected.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of equity in lieu of cash preserves the company's cash reserves.

Industry Context

Directors receiving equity in lieu of cash compensation is a common practice to align their interests with shareholders and conserve company cash.

Related Party Transactions

• The issuance of shares to Bonnie L. Bassler, a director, in lieu of a cash retainer payment is a related party transaction.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively, as it aligns her interests with theirs.
• The company benefits from preserving cash by issuing equity instead of cash for director compensation.

Key Dates